Loading…
Loading…
Home › All recalls › Prescription medicine
Category
Prescription drugs recalled for contamination, potency or labelling.
Or try another category
1,991 recalls · newest first
Defective container:may contain bottles with incomplete seals
Defective container:may contain bottles with incomplete seals
cGMP deviations
Subpotent Drug
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Failed Stability Specifications
Failed Impurities/Degradations Specifications
Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability…
CGMP Deviations; presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the FDA acceptable intake limit.
Subpotent Drug
Presence of Particulate matter: Particulate matter identified as glass.
Lack of Assurance of Sterility
Defective Container; packets were found to be either empty or partially full.
Labeling: Not Elsewhere Classified- Incomplete inactive ingredient information on the carton labeling.
Lack of Assurance of Sterility
Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications
Failed Impurities/Degradation Specifications
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule.